On Tuesday, the Centers for Medicare & Medicaid Services (CMS) approved the Advanced Diagnostic Laboratory Test (ADLT) status for Guardant Health, Inc.’s (NASDAQ:GH) Shield blood test for colorectal ...
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to ...
Guardant Health has filed a lawsuit against its competitor, Natera, alleging the misappropriation of trade secrets related to cancer-detection blood tests, according to court documents. According to ...
Hosted on MSN
Guardant’s New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases.
Next month, Guardant Health will launch a blood test that detects many kinds of cancers—putting itself on the heels of diagnostics rival Exact Sciences in the multicancer blood-screen race started by ...
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback